Immune-system frailty in adults 65 and older is a widespread public health issue. A study led by the Department of Immunobiology at the University of Arizona College of Medicine – Tucson points to new cells that may hold a solution.Continue reading
Author Archive: AZBio
What Happens When We Activate The Arizona Collaborative Gene
Arizona heats things up at BIO 2016
Continue reading
Arizona Biotech Industry Report Card Released at BIO 2016
The Biotechnology Innovation Organization (BIO) has released the Industry Report Cards for all 50 states today at the BIO International Convention
Arizona holds its position at Tier II in number of biotech firms and Tier III in biotech employment
Investments in research and development (R&D) and programs encouraging private investments in Arizona innovator companies is the state’s greatest opportunity for driving future high-wage job growth in the life science sector.Continue reading
National Bioscience Report Shows Industry Creating Jobs and Driving Innovation
Bioscience industry contributing to U.S. economic growth and improving quality of life for patientsContinue reading
Castle Biosciences Announces Clinical Results of Melanoma Gene Expression Test in 334-Patient Performance Cohort Study at ASCO 2016
Results confirm accuracy of DecisionDx-Melanoma to identify recurrence risk; A second independent, prospective study confirms test accuracy
BIO survey to support PDUFA 6 negotiations
Please take a few minutes to log in to BIO’s FDA survey and provide feedback on your company’s interactions with FDA.Continue reading
C-Path and CDISC Announce Updated Therapeutic Area Standard for TB
The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the open availability of an updated CDISC Therapeutic Area (TA) Standard for tuberculosis (TB). The tuberculosis v2.0 standard is an updated version of the original TB v1.0 standard and includes new content focused on pediatrics and drug susceptibility testing.Continue reading
Systems Imagination partners with Macrogen Corp. to provide superior genomic data generation and integrated analytical services.
Systems Imagination (SII), a knowledge evolution company, announced today a partnership with Macrogen Corp. of Rockville, Maryland, the integrated genomic service provider and precision medicine biotechnology company.Continue reading
CTCA Western clinical research director authors five innovative studies presented at ASCO
Dr. Glen Weiss is a Translational Physician Scientist (TPS) with a joint appointment at TGen and Cancer Treatment Centers of America. He is board certified in internal medicine and medical oncology. He is currently Co-Head of the Lung Cancer Unit and Clinical Associate Professor at TGen, Director of Clinical Research at Cancer Treatment Centers of America, and holds a Clinical Assistant Professor of Medicine appointment at the University of Arizona College of Medicine-Phoenix.Continue reading
VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta
PHOENIX, Ariz. (June 2, 2016) – VisionGate, Inc. today announced the appointment of Dr. Javier Zulueta as its Chief Medical Officer. A world-renowned pulmonologist, professor and 16-year Director of Pulmonary Service at the University Clinic of Navarra, the teaching hospital of Spain’s University of Navarra School of Medicine, Dr. Zulueta will provide expert counsel and oversight of VisionGate’s clinical collaborations and associated clinical trials in lung cancer early detection and chemoprevention therapy.Continue reading